Citalopram 20 Oethmaan 20 mg FC tablets
PDF Leaflet Revision Date: 09 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression, panic disorders, and OCD.
Dosage (summary)
20 mg daily for depression; 10 mg daily for panic disorder (increased to 20 mg); max 60 mg.
Onset of Action / Duration
Onset: 2-4 weeks
Special Populations
- Elderly: max 30 mg
- Hepatic impairment: halve dose
- Renal impairment: no adjustment for mild/moderate
Pregnancy & Breastfeeding
Safety not established; may affect neonates; excreted in breast milk.
Key Drug Interactions
- MAOIs
- Pimozide
- Serotonergic medicines
Contraindications
- Hypersensitivity
- Severe renal impairment
- QT prolongation
- Children under 18
Common side effects
- Nausea
- Insomnia
- Somnolence
- Dry mouth
- Sweating
Counselling Points
- Avoid abrupt discontinuation.
- Monitor for worsening depression or suicidality.
- Caution with alcohol.
Serious warnings
- Suicidal ideation
- QT interval prolongation
- Serotonin syndrome
Important Disclaimer
The Citalopram 20 Oethmaan 20 mg FC tablets professional information leaflet below is the property of Oethmaan Biosims and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
